Principal Scientist/Associate Director, DMPK

About Disc Medicine

discmedicine.com

Disc Medicine is a clinical‑stage biopharmaceutical company focused on developing first‑in‑class therapeutics for hematologic disorders. The company harnesses breakthrough science to translate discoveries into medicines designed to disrupt the current standard of care and improve outcomes for patients and families. Its pipeline includes programs in clinical development and the company works closely with patients, healthcare professionals, investors and partners to advance those therapies. Headquartered in Watertown, Massachusetts, Disc Medicine provides medical, investor and partnership contact channels via its website.

Recent company news

MarketBeat

First Light Asset Management LLC Acquires New Holdings in Disc Medicine, Inc. $IRON

15 hours ago

Business Wire

IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm

2 days ago

STAT

FDA rejects rare disease therapy from Disc Medicine, early recipient of commissioner’s voucher

1 month ago

Reuters

US FDA declines to approve Disc Medicine's rare disease drug

1 month ago

Simply Wall St

Is Disc Medicine (IRON) Pricing Attractive After Recent Pullback And DCF Valuation Gap

5 days ago